Related references
Note: Only part of the references are listed.Identification of cells initiating human melanomas
Tobias Schatton et al.
NATURE (2008)
Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4
Matilde Todaro et al.
CELL STEM CELL (2007)
The fuzzy math of solid tumor stem cells: A perspective
Scott E. Kern et al.
CANCER RESEARCH (2007)
Tumor growth need not be driven by rare cancer stem cells
Priscilla N. Kelly et al.
SCIENCE (2007)
Phenotypic characterization of human colorectal cancer stem cells
Piero Dalerba et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells
Maria M. Ho et al.
CANCER RESEARCH (2007)
Myc deletion rescues Apc deficiency in the small intestine
Owen J. Sansom et al.
NATURE (2007)
c-Myb is required for progenitor cell homeostasis in colonic crypts
Jordane Malaterre et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Molecular definition of breast tumor heterogeneity
Michail Shipitsin et al.
CANCER CELL (2007)
A human colon cancer cell capable of initiating tumour growth in immunodeficient mice
Catherine A. O'Brien et al.
NATURE (2007)
Identification and expansion of human colon-cancer-initiating cells
Lucia Ricci-Vitiani et al.
NATURE (2007)
Epithelial-mesenchymal transition and colorectal cancer: Gaining insights into tumor progression using LIM 1863 cells
Richard C. Bates et al.
CELLS TISSUES ORGANS (2007)
Establishment of human colon cancer cell lines from fresh tumors versus xenografts: Comparison of success rate and cell line features
Virginie Dangles-Marie et al.
CANCER RESEARCH (2007)
RNAi-mediated knockdown of aldehyde dehydrogenase class-1A1 and class-3A1 is specific and reveals that each contributes equally to the resistance against 4-hydroperoxycyclophosphamide
Jan S. Moreb et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Glioma stem cells promote radioresistance by preferential activation of the DNA damage response
Shideng Bao et al.
NATURE (2006)
Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc
Vanesa Muncan et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
Strategies to eliminate cancer stem cells: Clinical implications
CA Huff et al.
EUROPEAN JOURNAL OF CANCER (2006)
The epithelial-mesenchymal transition: new insights in signaling, development, and disease
JM Lee et al.
JOURNAL OF CELL BIOLOGY (2006)
Transplanted ALDHhiSSClo neural stem cells generate motor neurons and delay disease progression of nmd mice, an animal model of SMARD1
S Corti et al.
HUMAN MOLECULAR GENETICS (2006)
Prospective identification of tumorigenic prostate cancer stem cells
AT Collins et al.
CANCER RESEARCH (2005)
c-Myc is required for the formation of intestinal crypts but dispensable for homeostasis of the adult intestinal epithelium
MD Bettess et al.
MOLECULAR AND CELLULAR BIOLOGY (2005)
Multiple drug resistance in cancer revisited: The cancer stem cell hypothesis
VS Donnenberg et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2005)
Side population is enriched in tumorigenic, stem-like cancer cells, whereas ABCG2+ and ABCG2- cancer cells are similarly tumorigenic
L Patrawala et al.
CANCER RESEARCH (2005)
Breast cancer resistance protein (BCRP/ABCG2)
F Staud et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Metabolism and transport of oxazaphosphorines and the clinical implications
J Zhang et al.
DRUG METABOLISM REVIEWS (2005)
Retinoic acid down-regulates aldehyde dehydrogenase and increases cytotoxicity of 4-hydroperoxycyclophosphamide and acetaldehyde
JS Moreb et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2005)
Acute promyelocytic leukemia as a paradigm for targeted therapy
MS Tallman
SEMINARS IN HEMATOLOGY (2004)
A distinct side population of cells with high drug efflux capacity in human tumor cells
C Hirschmann-Jax et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Functional characterization of highly purified human hematopoietic repopulating cells isolated according to aldehyde dehydrogenase activity
DA Hess et al.
BLOOD (2004)
Granulocyte-macrophage progenitors as candidate leukemic stem cells in blast-crisis CML
CHM Jamieson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
ALCAM/CD166 is overexpressed in colorectal carcinoma and correlates with shortened patient survival
W Weichert et al.
JOURNAL OF CLINICAL PATHOLOGY (2004)
Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism
V Vasiliou et al.
DRUG METABOLISM REVIEWS (2004)
Retinoids in cancer therapy and chemoprevention: promise meets resistance
SJ Freemantle et al.
ONCOGENE (2003)
Mobilized peripheral blood SSCloALDHbr cells have the phenotypic and functional properties of primitive haematopoietic cells and their number correlates with engraftment following autologous transplantation
P Fallon et al.
BRITISH JOURNAL OF HAEMATOLOGY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The β-catenin/TCF-4 complex imposes a crypt progenitor phenotype on colorectal cancer cells
M van de Wetering et al.
CELL (2002)
Cellular levels of aldehyde dehydrogenases (ALDH1A1 and ALDH3A1) as predictors of therapeutic responses to cyclophosphamide-based chemotherapy of breast cancer:: a retrospective study -: Rational individualization of oxazaphosphorine-based cancer chemotherapeutic regimens
NE Sládek et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Stem cells, cancer, and cancer stem cells
T Reya et al.
NATURE (2001)
Metabolism and pharmacokinetics of oxazaphosphorines
AV Boddy et al.
CLINICAL PHARMACOKINETICS (2000)
Share Paper
